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Histopathology of Human Renal Allograft Rejection under FK 506: A 
Comparison With Cyclosporine 
A.J. Demetris. B. Banner. J. Fung, R. Shapiro. M. Jordan. and T.E. Starzl 
PK 506. a powerful new immunosuppressant. was first 
used in humans in an attempt to salvage liver and 
kidney allografts that were failing because of rejection. I 
Thereafter. allograft recipients who were experiencing 
disabling side effects of standard cyclosporine (CyA! and 
steroid baseline therapy were switched to FK 506 as well. I 
The relative safety of the drug then permitted trials of FK 
506 as the initial immunosuppressant as maintenance ther-
apy for primary liver allograft recipients. 2 Bolstered by the 
success with liver allografts. FK 506 was tested as primary 
therapy in recipients of new kidney allografts. 3 
In our initial report. we detailed the pathologic findings 
in the earliest recipients of FK 506. most of whom had 
received liver allografts. 4 Comparison of the incidence and 
histologic features of acute cellular rejection in this group 
to historic controls maintained on CyA revealed some 
distinct differences. First. the incidence of acute cellular 
rejection was less in those treated with FK 506 than in the 
historic CyA treated control~K4 Second. although the his-
tologic appearance of liver allograft rejection in patients 
treated with FK 506 was similar to that seen under CvA 
and steroids.4 central venulitis as pan of rejection ~·as 
more prominent in the former. This report focuses on the 
histopathology of renal allograft rejection in comparison to 
contemporaneous Cy Alsteroid treated controls. 
Since the initial renal allograft recipients treated with 
FK 506 were "high risk." they were not randomly as-
signed to treatment groups. J Also. the renal biopsies in this 
series of patients were performed because of dissatisfac-
tion with the clinical course or uncertainty about the 
Table 1. Patient and PathologiC Data and Immunologic Profile 
Prior to Transplant 
CyA FJ< 506 
Patients 26 19 
Ma\e.1emale 1719 11/8 
Average age (range) 41(16-72) 4OE1U~TF 
Biopsies 70 36 
Failed allografts 7 3 
Prior kidney transplant 4(15%) 5(26%) 
Pediatric en bloc 6(25%) 2(11%) 
Living related donor 2(8'1'.) 0 
PRA >OM"~D 4(16%) 6(32%) 
EQUivalent or poSItive crossmatch t 9(36%) 7(37%) 
Average antigen matches (range) 1.9(CHi) 1.5(0-3) 
Note. None 01 the dillerenc:es are SIaIisIicaIy signilicant (chi·square analysis) 
exa!pl1or the use 01 living refated doI'Wn 11l1li CyA ~K 
Abbreviations: PRA. panel reactive body. 
·Based on current or historic (less ... 6 mcnlhS) sera. 
t~ or frankly positive ~ alter treatment wiIh dithioIIveiIoI 
(OTT). 
diagnosis. It should be noted that pathology specimens 
were obtained more often in the CyA treated patients. 
Therefore. a distinct comparison ofthe incidence or sever-
ity of rejection was not considered valid. We had. how-
ever. more simple goals in mind forthis initial study. They 
were (I) to determine if histologic features observed in 
renal allograft biopsies during episodes of clinically sus-
pected rejection differ in patients with FK 506 compared 
with those treated with CyA as the baseline immunosup-
pressant: (::!) to determine if histologic features associated 
with clinical rejection correlate with renal dysfunction as 
measured by serum creatinine levels: and (3) to determine 
if classic prognostic features of rejection are valid under 
this new immunosuppressive agent. 
PATIENTS AND METHODS 
The patients were selected for this study on the basis that they 
received a renal allograft in the 6-month period between June and 
December 1989. Furthermore. each of the patients expenenced 
graft d~yfunction within the first 3 posllransplant months for 
\10 hich a needle biopsy was pert"ormed. The patlellts chosen 
included 26 who were treated with CyA and 19 immunosup-
pressed with FK 506 as the baseline drug. Both groups EC~K-y and 
FK 5061 of patients were initially given steroids. a1thoug:h the 
d~es .... ere rapidly tapered in the FK 506 groups.; Therefore. 
maintenance steroid therapy was. on the average. much lo"'er in 
the FK 506 treated group. General patient data. the number and 
t~ pe of pathology specimens. and the immunologic status pnor to 
transplantation are shown in Table I. Then was no difference in 
the type or incidence of native renal diseases between the two 
groups .data not shown I. 
Table 2. Histologic Features Assessed In the Coded Review 
of Slides 
S1rucIure 
Glomerulus 
Tubular epithelium 
Interstilil.ln 
Arteoole.'ar1eries 
Featul1l Assessed 
Average number, celularity, capiIary loop 
integrity and thrormosis. and aescens 
Vacuolization. necrosa-sloughing. inflamma-
tion 
Edema. fibrosis (seventy). inflammation lse-
verity and type), hemorrhage.necroSIS 
Thrombosis. fibrinoid necrosis. inftamma10ry 
arteritis. arteriolar ttickening 
From the Department of Pathology. Division of TransplantatIOn, 
Presbyterian University Hospital, Pittsburgh, Pennsylvania. 
Address repfi1ts to A.J. Demetris. Dep8l1ment of Pathology. 
Division of Transplantation, Presbyterian University HospiIal, Pitts-
burgh. PA 15213. 
{; 1991 by Appleton & Lange 
MM41-1P4R191/~Kllf+l 
944 Transplantation Proceedings, Vol 23, No 1 (February), 1991: pp 944-946 
'imens 
lients. 
,ever-
how-
They 
ed in 
sus-
1ared 
lSUp-
;ated 
·n· as 
nine 
lder 
hey 
and 
,;ed 
for 
Jp-
nd 
he 
-e. 
in 
1d 
10 
in 
o 
COMPARISON OF FK 506 AND CVA 
Tabl. 3. IncidenC' of HIstopathologIc Changes Observed In the 
Allograft Biopsies and Failed Allografts 
CyA FK506 
GJotneruli 
Average nur-oer" 9 15 
Cellularity 
Normal 51 28 
Increased 22(30%) 10(26%) 
thrombi" 19(25%) 4(11%) 
Crescents 1 1 
'In tJiOpSies cnt· 
'Most were SW' 111 biopsies taken during the first postIranspla/'ll week and most 
IiUly represent preservation related changes. 
All biopsies were performed upon clinical indication. Coded 
biopsy slides .. ere revie .. ed in sequence. separately by the two 
pathologists. They had no knowledge of the type or changes in 
immunosuppmsive therapy. The presence or absence. and where 
appropriate. tilt degree of histologic changes were scored for each 
biopsy. The histologic features assessed are shown in Table 2. A 
diagnosis was then rendered and the results compared. Conven-
tional histopathologic criteria were used as the basis for the 
diagnosis of acute cellular and humoral rejection. Thereafter. any 
result showing disagreement between the pathologists for a par-
ticular feature was re-reviewed and a consensus was made. 
Thereafter. tilt treatment code was broken. 
RESULTS 
Histopathologic Changes 
The changes observed in the glomeruli are listed in Table 
3. There was no statistically significant difference in the 
findings between the two groups. The thrombi seen in the 
glomeruli were most commonly observed in the first post-
transplant week and likely related to preservation. Drug 
treatment rna}' also be contributory. 
Tubular epithelial changes were most commonl\' seen in 
the proximal convoluted portion. These are summ~rized in 
Table 4. No statistically significant differences ""ere seen 
between the two groups. 
The interstitial changes are summarized in Table 5. 
Again. there was no statistically significant difference 
between the two groups. The composition of the infiltrate 
was also evaluated by light microscopy and no significant 
differences was noted. 
The histologic changes observed in the arteriaJ tree are 
summarized in Table 6. Again. no statistically significant 
difference was noted between the two groups. The pres-
ence of fibrinoid necrosis was accompanied by immune 
deposits and/or interstitial inftammation in both groups. 
Table 4. Summary 01 the IncIdence of Proximal Tubular 
EpIthelial Changes 
Normal 
Vacuolated 
Necrosis/sloughing" 
CyA 
("4) 
7 (9) 
29(38) 
10 (13) 
FK 506 ("4) 
5 (13) 
12 (31) 
4(10) 
945 
Table S. Sunvnary of the Incidence of Histopathologic 
Interstitial Changes 
CyA FK506 
("4) (%) 
Edema 19(26) 9 (23) 
Fibrosis 
None 40(52) 19(49) 
Mild 28(36) 14 (36) 
Moderate 5(6) 6 (15) 
Severe 0 0 
Inflammation 
None 17 (22) 8 (21) 
Mild 39(51) 21 (54) 
Moderate 18(23) 7 (18) 
Severe 2 (3) 2(5) 
Hemorrhage 16(22) 4 (11) 
This indicates the necrosis observed was likely a conse-
quence of rejection. 
HistopathologiC Diagnosis and Clinicopathologic Correlation 
A summary of the incidence of the histopathologic diag-
nosis of rejection is shown in Table 7. As can be seen. 
there was no statistically significant difference between the 
two groups. The clinicopathologic correlation for the pa-
tients treated \\ ith FK 506 is shown in Table 8. Rejection 
(cellular and humoral) was treated by an increase in FK 
506. steroids. or OKT3. As can be seen. treatment of 
changes typically associated with acute cellular rejection 
resulted in an improvement in renal function as assessed 
by serum creatinine. No response. however. was observed 
in patients with humoral rejection. 
Finall y. classic prognostic features associated with a 
poor prognosis in rejection were analyzed in both groups. 
The presence of arterial fibrinoid necrosis and intestinal 
hemorrhage in either group presuaged graft failure in most 
instances. For patients treated with FK 506. three of the 
four patients who had intestinal hemorrhage in biopsy 
specimens lost their graft in the first 3 months (P < .05 
chi-square analysis I. 
DISCUSSION 
This pilot study demonstrates that conventional histo-
pathologic criteria for the diagnosis of acute cellular and 
humoral rejection of renal allografts can be applied to 
biopsies from human kidney graft recipients treated with 
FK 506. Although there was a trend toward a lower 
Table e. SU""'*Y 01 the incidence of Changes In the 
ArteNI Tree 
CyA 
("At) FK506(%) 
Thrombosis 9 (12) 4 (11) 
Fibrinoid necrosis 10 (14) 2(6) 
Inflanvnatory arteritis 24(32) 7 (19) 
Arteriolar thickening 24 (33) 17 (46) 
-_.--------_.-. 
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Table 7. Incidence of the Histopathologic Diagnosis 
of Rejection 
CyA FK 506 
("to) ("to) 
Predominantly hu- 3 (4) 3 (8) 
moral rejection 
Predominantly cellular 54 (70) 23 (60) 
rejection 
Other 20 (26) 13 (32) 
incidence of findings associated with more severe rejection 
in patients treated with FK 506. the differences were not 
statistically significant in this small population. Further-
more, the number of biopsies in Cy A treated patients was 
greater. Some of the features commonly associated with 
CyA nephrotoxicity (proximal tubular vacuolization and 
glomular thrombosis) were also observed in biopsies from 
patients treated with FK 506. The effect, if any, of FK 506 
or renal structural integrity will require long-term fol-
low-up studies. Finally, a more direct comparison of the 
two drugs will have to be assessed in a randomized trial. 
currently underway. 
DEMETRIS. BANNER. FUNG ET P. 
q~ 8, Clinicopathologic Correlation Between the Biopsy DI-
agnosis, Change In Immunosuppressive Therapy, and Etrect on 
Renal Function In Patient Treated WIth FK S06 
Pathology No. of Alteration in IS Change It" s"ruc 
()aqnosIs Pahents Therapy Crea:Jnl:'le 
ACR 7 Increased Decreased 
ACR 1 No change Decreased 
Predominantly 3 Increased Increaseo 
tvnoral 
Other 3 Decreased Decreased 
Other 4 No change Decreasec or 
same 
Atuevialions: IS. immunosuppressive 1I'Ierapy; ACR. aeule cellular rllfecllOn. 
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